Biotechnology Fund Class Fund Market Value

RYCFX Fund  USD 44.28  0.37  0.84%   
Biotechnology Fund's market value is the price at which a share of Biotechnology Fund trades on a public exchange. It measures the collective expectations of Biotechnology Fund Class investors about its performance. Biotechnology Fund is trading at 44.28 as of the 16th of February 2026; that is 0.84 percent increase since the beginning of the trading day. The fund's open price was 43.91.
With this module, you can estimate the performance of a buy and hold strategy of Biotechnology Fund Class and determine expected loss or profit from investing in Biotechnology Fund over a given investment horizon. Check out Biotechnology Fund Correlation, Biotechnology Fund Volatility and Biotechnology Fund Performance module to complement your research on Biotechnology Fund.
Symbol

It's important to distinguish between Biotechnology Fund's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biotechnology Fund should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Biotechnology Fund's market price signifies the transaction level at which participants voluntarily complete trades.

Biotechnology Fund 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotechnology Fund's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotechnology Fund.
0.00
11/18/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/16/2026
0.00
If you would invest  0.00  in Biotechnology Fund on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Biotechnology Fund Class or generate 0.0% return on investment in Biotechnology Fund over 90 days. Biotechnology Fund is related to or competes with Eic Value, Boyd Watterson, Auer Growth, Federated Bond, Omni Small-cap, Qs Us, and Rbc Funds. Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology C... More

Biotechnology Fund Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotechnology Fund's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotechnology Fund Class upside and downside potential and time the market with a certain degree of confidence.

Biotechnology Fund Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotechnology Fund's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotechnology Fund's standard deviation. In reality, there are many statistical measures that can use Biotechnology Fund historical prices to predict the future Biotechnology Fund's volatility.
Hype
Prediction
LowEstimatedHigh
40.6644.2847.90
Details
Intrinsic
Valuation
LowRealHigh
43.0946.7150.33
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Biotechnology Fund. Your research has to be compared to or analyzed against Biotechnology Fund's peers to derive any actionable benefits. When done correctly, Biotechnology Fund's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Biotechnology Fund Class.

Biotechnology Fund February 16, 2026 Technical Indicators

Biotechnology Fund Class Backtested Returns

Biotechnology Fund appears to be very steady, given 3 months investment horizon. Biotechnology Fund Class secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the fund had a 0.15 % return per unit of risk over the last 3 months. By analyzing Biotechnology Fund's technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please makes use of Biotechnology Fund's Downside Deviation of 1.13, risk adjusted performance of 0.1347, and Mean Deviation of 1.41 to double-check if our risk estimates are consistent with your expectations. The fund shows a Beta (market volatility) of 0.19, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Biotechnology Fund's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biotechnology Fund is expected to be smaller as well.

Auto-correlation

    
  0.12  

Insignificant predictability

Biotechnology Fund Class has insignificant predictability. Overlapping area represents the amount of predictability between Biotechnology Fund time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotechnology Fund Class price movement. The serial correlation of 0.12 indicates that less than 12.0% of current Biotechnology Fund price fluctuation can be explain by its past prices.
Correlation Coefficient0.12
Spearman Rank Test0.03
Residual Average0.0
Price Variance0.26

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in BIOTECHNOLOGY Mutual Fund

Biotechnology Fund financial ratios help investors to determine whether BIOTECHNOLOGY Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIOTECHNOLOGY with respect to the benefits of owning Biotechnology Fund security.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios